Ocumension Therapeutics is based in Suzhou, China. It has raised $200M in total funding. Latest round: IPO.
Ocumension Therapeutics funding overview
Ocumension Therapeutics is based in Suzhou, China. Ocumension Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in July 2020. The round record for Ocumension Therapeutics runs through 2020; nothing later has been disclosed.
Ocumension Therapeutics at a glance
Total raised
$200M
Latest round
IPO
Latest round date
July 2020
Headquarters
Suzhou, China
Frequently asked about Ocumension Therapeutics funding
How much has Ocumension Therapeutics raised?
Ocumension Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Ocumension Therapeutics?
No investors are named on the public record for Ocumension Therapeutics yet.
What was the latest Ocumension Therapeutics funding round?
The most recent disclosed round is an IPO, announced in July 2020.
Where is Ocumension Therapeutics based?
Ocumension Therapeutics is based in Suzhou, China.
When did Ocumension Therapeutics last raise?
The last disclosed Ocumension Therapeutics round closed in July 2020 at IPO.
Ocumension Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
